STOCK TITAN

Kennerman Associates (INIS) files 42.4% beneficial stake disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Radnostix, Inc. disclosure: Kennerman Associates, Inc. reports beneficial ownership of 237,489,559 shares of common stock, representing 42.4% of the class based on March 26, 2026. The holding includes 5,000,000 vested options exercisable within 60 days and 26,300,000 shares issuable on conversion of Series C Preferred Stock.

Christopher Grosso is identified as a principal of Kennerman Associates and is reported as beneficially owning 65,645,540 shares (12.1%), which includes options and Series C conversion rights; Grosso disclaims beneficial ownership of a portion of the securities reported.

Positive

  • None.

Negative

  • None.
Kennerman shares beneficially owned 237,489,559 shares ownership reported in Schedule 13G
Kennerman percent of class 42.4% based on 528,209,538 shares outstanding as of March 26, 2026
Vested options included 5,000,000 shares options exercisable within 60 days
Series C conversion (Kennerman) 26,300,000 shares issuable upon conversion of Series C Preferred Stock
Christopher Grosso beneficial ownership 65,645,540 shares reported aggregate beneficial ownership
Grosso percent of class 12.1% based on 523,706,140 shares outstanding as of March 26, 2026
beneficial ownership regulatory
"Amount beneficially owned: As of the date of this filing"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Series C Convertible Redeemable Preferred Stock financial
"26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemed Preferred Stock"
vested stock options exercisable within 60 days financial
"5,000,000 shares of common stock subject to vested stock options exercisable within 60 days"





45972C102

(CUSIP Number)
12/31/2025

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemed Preferred Stock (2) Based on 528,209,538 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report on Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Includes 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 5,040,000 shares of common stock issuable upon conversion of Series C Preferred Stock. (2) Includes (i) 2,189,697 shares of common stock and (ii) 2,000,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's father's, for which the reporting person shares investment control. (3) Includes (i) 562,884 shares of common stock and (ii) 350,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's son, for which the reporting person shares investment control. (4) Based on 523,706,140 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report of Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G



Kennerman Associates, Inc.
Signature:/s/ Kennerman Associates, Inc.
Name/Title:President
Date:05/14/2026
GROSSO CHRISTOPHER G
Signature:/s/ Christopher Grosso
Name/Title:Christopher Grosso
Date:05/14/2026

FAQ

What stake does Kennerman Associates report in INIS?

Kennerman Associates reports beneficial ownership of 237,489,559 shares, equal to 42.4% of the class based on March 26, 2026. This total includes vested options exercisable within 60 days and shares issuable upon conversion of Series C Preferred Stock.

How much of INIS does Christopher Grosso beneficially own?

Christopher Grosso is reported as beneficially owning 65,645,540 shares, or 12.1% of the class based on the filing. His reported total includes vested options and shares issuable upon conversion of Series C Preferred Stock, and he disclaims ownership of certain securities.

Which convertible or option instruments are included in the reported INIS holdings?

The reported holdings include 5,000,000 vested options exercisable within 60 days and 26,300,000 shares issuable upon conversion of the issuer's Series C Convertible Redeemable Preferred Stock, as stated in the filing's comment section.

What outstanding share bases does the filing cite for INIS percentages?

The filing cites two outstanding share figures: 528,209,538 shares as of March 26, 2026 and 523,706,140 shares as of March 26, 2026 in related statements; each outstanding count is used to calculate the reported percentage ownership in the cover comments.